CING
Cingulate Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.10
−2.30%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-122.7%
Return on equity
-87.1%
Return on assets
-83.7%
Return on invested capital
0.00x
Asset turnover
-$20.7M
Cash from operations
$1.95
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026